These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Late onset of EBV-driven PTLD/Burkitt lymphoma/leukemia in a patient 10 years after allogeneic stem cell transplant for AML. Huang Q; Popplewell L; Lu Y; Slovak ML; Forman SJ Bone Marrow Transplant; 2010 Jan; 45(1):191-4. PubMed ID: 19430500 [No Abstract] [Full Text] [Related]
25. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Taylor AL; Marcus R; Bradley JA Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320 [TBL] [Abstract][Full Text] [Related]
26. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center]. Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748 [TBL] [Abstract][Full Text] [Related]
27. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Styczynski J; Einsele H; Gil L; Ljungman P Transpl Infect Dis; 2009 Oct; 11(5):383-92. PubMed ID: 19558376 [TBL] [Abstract][Full Text] [Related]
28. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Weinstock DM; Ambrossi GG; Brennan C; Kiehn TE; Jakubowski A Bone Marrow Transplant; 2006 Mar; 37(6):539-46. PubMed ID: 16462755 [TBL] [Abstract][Full Text] [Related]
29. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Lekakis L; de Lima M Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]